In general, phosphorylated EIF4EBP1 is considered as an indicator of oncogenic activity in tumor and associated with poor survival of cancer patients [19–22], while unphosphorylated EIF4EBP1 functions as a tumor suppressor [23–25]. Here, EIF4EBP1 is linked to neoplasm.